Rosetta Genomics Ltd.
DelistedCIK 1362959fmd_109F2Q3WW22MKJ1G83JP565FWAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2017, 15 periods
Latest annual · FY2016
Millions- Total revenues
- 2
- Gross profit
- 0
- Operating income
- (13)
- Net income
- (16)
- Free cash flow
- 10
Latest quarter · Q2 FY2017
Millions- Total revenues
- 1
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2013 to FY2016
- +71.4%
- Revenue, 5 yearsFY2011 to FY2016
- +81.7%
- Net income, 5 yearsFY2011 to FY2016
- n/m
Rosetta Genomics Ltd. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $2 million | $2.9 million | -29.1% | 6-K 2017-10-10 · proof |
| Gross profit | $498,000 | $1.9 million | -73.4% | 6-K 2017-10-10 · proof |
| Operating income | -$12.6 million | -$12.9 million | 6-K 2017-10-10 · proof | |
| Net income | -$16.2 million | -$17.3 million | 6-K 2017-10-10 · proof | |
| Cash from operating activities | $10.4 million | -$16.9 million | 6-K 2017-10-10 · proof | |
| Free cash flow | $10.3 million | -$17.1 million | 6-K 2017-10-10 · proof | |
| Total assets | $12 million | $22.4 million | -46.7% | 20-F 2017-03-30 · proof |
| Total liabilities | $874,000 | $656,000 | +33.2% | 6-K 2017-10-10 · proof |
| Cash and cash equivalents | $4.6 million | $11.1 million | -58.7% | 6-K 2017-10-10 · proof |
- What was Rosetta Genomics Ltd.'s revenue in fiscal 2016?
- Rosetta Genomics Ltd. reported revenue of $2 million for fiscal 2016 (the year ended Dec 31, 2016), against $2.9 million the year before (-29.1%). Source: the 6-K filed with the SEC on Oct 10, 2017 (restated). SEC
- What was Rosetta Genomics Ltd.'s gross profit in fiscal 2016?
- Rosetta Genomics Ltd. reported gross profit of $498,000 for fiscal 2016 (the year ended Dec 31, 2016), against $1.9 million the year before (-73.4%). Source: the 6-K filed with the SEC on Oct 10, 2017 (restated). SEC
- What was Rosetta Genomics Ltd.'s operating income in fiscal 2016?
- Rosetta Genomics Ltd. reported operating income of -$12.6 million for fiscal 2016 (the year ended Dec 31, 2016), against -$12.9 million the year before. Source: the 6-K filed with the SEC on Oct 10, 2017 (restated). SEC
- What was Rosetta Genomics Ltd.'s net income in fiscal 2016?
- Rosetta Genomics Ltd. reported net income of -$16.2 million for fiscal 2016 (the year ended Dec 31, 2016), against -$17.3 million the year before. Source: the 6-K filed with the SEC on Oct 10, 2017 (restated). SEC
- What was Rosetta Genomics Ltd.'s cash from operating activities in fiscal 2016?
- Rosetta Genomics Ltd. reported cash from operating activities of $10.4 million for fiscal 2016 (the year ended Dec 31, 2016), against -$16.9 million the year before. Source: the 6-K filed with the SEC on Oct 10, 2017 (restated). SEC
- What was Rosetta Genomics Ltd.'s free cash flow in fiscal 2016?
- Rosetta Genomics Ltd. reported free cash flow of $10.3 million for fiscal 2016 (the year ended Dec 31, 2016), against -$17.1 million the year before. Source: the 6-K filed with the SEC on Oct 10, 2017 (restated). SEC
- What are Rosetta Genomics Ltd.'s total assets?
- As of Dec 31, 2016, Rosetta Genomics Ltd. reported total assets of $12 million, against $22.4 million a year earlier (-46.7%). Source: the 20-F filed with the SEC on Mar 30, 2017. SEC
- What are Rosetta Genomics Ltd.'s total liabilities?
- As of Dec 31, 2016, Rosetta Genomics Ltd. reported total liabilities of $874,000, against $656,000 a year earlier (+33.2%). Source: the 6-K filed with the SEC on Oct 10, 2017. SEC
- What are Rosetta Genomics Ltd.'s cash and cash equivalents?
- As of Dec 31, 2016, Rosetta Genomics Ltd. reported cash and cash equivalents of $4.6 million, against $11.1 million a year earlier (-58.7%). Source: the 6-K filed with the SEC on Oct 10, 2017 (restated). SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1362959&period_type=annual&limit=5"Information only, not investment advice.